OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
15
Results
Show all
Save search
Copy query
Show results for
Unknown
(15)
Publication Date
Release Date
2018
(3)
2022
(2)
2021
(2)
2025
(1)
2023
(1)
2020
(1)
2017
(1)
2016
(1)
2015
(1)
2014
(1)
2012
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Hemostatic markers are associated with the risk and prognosis of atrial fibrillation: the ARIC study.
Not available
S-EPMC3025309
|
biostudies-literature
Cite
Association of Intensive vs Standard Blood Pressure Control With Magnetic Resonance Imaging Biomarkers of Alzheimer Disease: Secondary Analysis of the SPRINT MIND Randomized Trial.
Not available
S-EPMC7941253
|
biostudies-literature
Cite
Kidney Disease, Hypertension Treatment, and Cerebral Perfusion and Structure.
Not available
S-EPMC8926938
|
biostudies-literature
Cite
Chronic kidney disease, cerebral blood flow, and white matter volume in hypertensive adults.
Not available
S-EPMC4818564
|
biostudies-literature
Cite
Prediction of disability-free survival in healthy older people.
Not available
S-EPMC9213595
|
biostudies-literature
Cite
Effect of Intensive Blood-Pressure Treatment on Patient-Reported Outcomes.
Not available
S-EPMC5706112
|
biostudies-literature
Cite
Final Report of a Trial of Intensive versus Standard Blood-Pressure Control.
Not available
S-EPMC9907774
|
biostudies-literature
Cite
Effect of Aspirin on Disability-free Survival in the Healthy Elderly.
Not available
S-EPMC6426126
|
biostudies-literature
Cite
Effect of Aspirin on All-Cause Mortality in the Healthy Elderly.
Not available
S-EPMC6433466
|
biostudies-literature
Cite
Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19: A Randomized Clinical Trial.
Not available
S-EPMC7653542
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets